| P2093 | author name string | Bruce W Hollis | |
| P2860 | cites work | Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men | Q22242854 |
| | On the epidemiology of influenza | Q27498323 |
| | Plasma vitamin D metabolites and risk of colorectal cancer in women | Q28212172 |
| | Radioreceptor assay for 1 alpha,25-dihydroxyvitamin D3 | Q28245826 |
| | Calcium plus vitamin D supplementation and the risk of colorectal cancer | Q28297713 |
| | Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response | Q28298985 |
| | Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D | Q28304322 |
| | Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey | Q31115409 |
| | Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial | Q33226868 |
| | Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method | Q33439254 |
| | Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction | Q34316970 |
| | Vitamin D2 is much less effective than vitamin D3 in humans | Q34365889 |
| | Calcium plus vitamin D supplementation and the risk of fractures | Q34495055 |
| | Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis | Q34573482 |
| | Vitamin D deficiency and risk of cardiovascular disease | Q34586829 |
| | Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy | Q34606365 |
| | Plasma 25-hydroxyvitamin D levels and risk of incident hypertension | Q34610247 |
| | 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study | Q37035497 |
| | Fighting infections with vitamin D | Q83104311 |
| | Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency | Q83322737 |
| | C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status | Q83832853 |
| | Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status | Q93630509 |
| | Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation | Q37036056 |
| | The paradoxical effects of vitamin D on type 1 mediated immunity | Q37079271 |
| | Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis | Q37109822 |
| | A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma | Q39115892 |
| | Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. | Q39606361 |
| | The physiologic significance of plasma transport of vitamin D and metabolites | Q39901226 |
| | Structure-function relationships in the vitamin D endocrine system | Q40545127 |
| | Exogenous versus endogenous recovery of 25-hydroxyvitamins D2 and D3 in human samples using high-performance liquid chromatography and the DiaSorin LIAISON Total-D Assay | Q43136938 |
| | Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. | Q43197058 |
| | 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey | Q43445970 |
| | Cell defenses and the sunshine vitamin | Q43656592 |
| | Competitive protein-binding radioassay for 25-hydroxycholecalciferol | Q43791446 |
| | Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer | Q44846719 |
| | Low vitamin d levels predict stroke in patients referred to coronary angiography | Q45246389 |
| | A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer | Q45305651 |
| | Serum 25-hydroxyvitamin D is unaffected by multiple freeze-thaw cycles | Q46147113 |
| | Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality | Q46523052 |
| | Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. | Q46601536 |
| | Phase switching SPE for faster 1,25-dihydroxyvitamin D analysis. 1986. | Q48533121 |
| | Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. | Q52253508 |
| | Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. | Q52944355 |
| | Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast Cancer | Q56087735 |
| | Serum 25-hydroxyvitamin D, Ethnicity, and Blood Pressure in the Third National Health and Nutrition Examination Survey | Q57385090 |
| | Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study | Q57419291 |
| | Circulating 25-Hydroxyvitamin D Levels Predict Survival in Early-Stage Non–Small-Cell Lung Cancer Patients | Q57896620 |
| | Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults | Q64127908 |
| | A Radioimmunoassay for 1,25-Dihydroxycholecalciferol | Q67289593 |
| | Importance of the isolation of 25-hydroxyvitamin D before assay | Q67318583 |
| | A rapid assay for 25-OH-vitamin D3 without preparative chromatography | Q68685985 |
| | Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure | Q70153551 |
| | Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer | Q70598693 |
| | Stability of vitamin D metabolites in human blood serum and plasma | Q70757448 |
| | Two direct (nonchromatographic) assays for 25-hydroxyvitamin D | Q70798190 |
| | A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies | Q70997434 |
| | Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer | Q71011309 |
| | Laboratory reporting of 25-hydroxyvitamin D results: potential for clinical misinterpretation | Q79306210 |
| | The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays | Q79465393 |
| | Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation | Q80161360 |
| | Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk | Q80173480 |
| | Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer | Q80568407 |
| | Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation | Q81196966 |
| | Normal serum vitamin D levels | Q81358169 |
| | Serum vitamin D measurement may not reflect what you give to your patients | Q81571382 |
| | Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography | Q81746932 |
| | Underestimation of serum 25-hydroxyvitamin D by the Nichols Advantage Assay in patients receiving vitamin D replacement therapy | Q81782232 |
| | HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays | Q83018244 |
| P433 | issue | 2 | |
| P304 | page(s) | 271-86, table of contents | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Endocrinology and Metabolism Clinics of North America | Q15763298 |
| P1476 | title | Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. | |
| P478 | volume | 39 | |